Search research articles
Contact Us
Filters
Showing results (51-60 of 97) with videos related to
Page
of 10
Sort By:
Frontiers in Cell and Developmental Biology
|
April 26, 2021
The Transcription Regulator Patz1 Is Essential for Neural Stem Cell Maintenance and Proliferation
Sara Mancinelli, Michela Vitiello, Maria Donnini, et al.
The Biochemical Journal
|
February 17, 2005
High-mobility-group A1 (HMGA1) proteins down-regulate the expression of the recombination activating gene 2 (RAG2)
Sabrina Battista, Monica Fedele, Josefina Martinez Hoyos, et al.
Scientific Reports
|
December 18, 2014
The dosage of Patz1 modulates reprogramming process
Hui Ma, Jin Rong Ow, Bobby Cheng Peow Tan, et al.
Cancer Research
|
November 13, 2003
Suppression of HMGA2 protein synthesis could be a tool for the therapy of well differentiated liposarcomas overexpressing HMGA2
Francesca Pentimalli, Monica Dentice, Monica Fedele, et al.
Pharmaceutics
|
October 27, 2022
Aptamer-Functionalized Nanoparticles Mediate PD-L1 siRNA Delivery for Effective Gene Silencing in Triple-Negative Breast Cancer Cells
Simona Camorani, Silvia Tortorella, Lisa Agnello, et al.
Endocrine-Related Cancer
|
October 5, 2007
The Mia/Cd-rap gene expression is downregulated by the high-mobility group A proteins in mouse pituitary adenomas
Ivana De Martino, Rosa Visone, Dario Palmieri, et al.
International Journal of Cancer
|
February 3, 2017
Complementary actions of dopamine D2 receptor agonist and anti-vegf therapy on tumoral vessel normalization in a transgenic mouse model
Norbert Chauvet, Nicola Romanò, Chrystel Lafont, et al.
Cancer Research
|
April 17, 2002
The High Mobility Group A2 gene is amplified and overexpressed in human prolactinomas
Palma Finelli, Giovanna Maria Pierantoni, Daniela Giardino, et al.
Scientific Reports
|
April 30, 2016
PATZ1 is a target of miR-29b that is induced by Ha-Ras oncogene in rat thyroid cells
Michela Vitiello, Teresa Valentino, Marta De Menna, et al.
Theranostics
|
November 16, 2018
Targeted imaging and inhibition of triple-negative breast cancer metastases by a PDGFRβ aptamer
Simona Camorani, Billy Samuel Hill, Francesca Collina, et al.
Page
of 10
Search research articles
Search
Showing results (51-60 of 97) with videos related to
Sort By:
Page
of 10
Frontiers in Cell and Developmental Biology
|
April 26, 2021
The Transcription Regulator Patz1 Is Essential for Neural Stem Cell Maintenance and Proliferation
Sara Mancinelli, Michela Vitiello, Maria Donnini, et al.
The Biochemical Journal
|
February 17, 2005
High-mobility-group A1 (HMGA1) proteins down-regulate the expression of the recombination activating gene 2 (RAG2)
Sabrina Battista, Monica Fedele, Josefina Martinez Hoyos, et al.
Scientific Reports
|
December 18, 2014
The dosage of Patz1 modulates reprogramming process
Hui Ma, Jin Rong Ow, Bobby Cheng Peow Tan, et al.
Cancer Research
|
November 13, 2003
Suppression of HMGA2 protein synthesis could be a tool for the therapy of well differentiated liposarcomas overexpressing HMGA2
Francesca Pentimalli, Monica Dentice, Monica Fedele, et al.
Pharmaceutics
|
October 27, 2022
Aptamer-Functionalized Nanoparticles Mediate PD-L1 siRNA Delivery for Effective Gene Silencing in Triple-Negative Breast Cancer Cells
Simona Camorani, Silvia Tortorella, Lisa Agnello, et al.
Endocrine-Related Cancer
|
October 5, 2007
The Mia/Cd-rap gene expression is downregulated by the high-mobility group A proteins in mouse pituitary adenomas
Ivana De Martino, Rosa Visone, Dario Palmieri, et al.
International Journal of Cancer
|
February 3, 2017
Complementary actions of dopamine D2 receptor agonist and anti-vegf therapy on tumoral vessel normalization in a transgenic mouse model
Norbert Chauvet, Nicola Romanò, Chrystel Lafont, et al.
Cancer Research
|
April 17, 2002
The High Mobility Group A2 gene is amplified and overexpressed in human prolactinomas
Palma Finelli, Giovanna Maria Pierantoni, Daniela Giardino, et al.
Scientific Reports
|
April 30, 2016
PATZ1 is a target of miR-29b that is induced by Ha-Ras oncogene in rat thyroid cells
Michela Vitiello, Teresa Valentino, Marta De Menna, et al.
Theranostics
|
November 16, 2018
Targeted imaging and inhibition of triple-negative breast cancer metastases by a PDGFRβ aptamer
Simona Camorani, Billy Samuel Hill, Francesca Collina, et al.
Page
of 10